SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Ota M.) "

Sökning: WFRF:(Ota M.)

  • Resultat 71-80 av 88
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
71.
  • Fröbert, Ole, 1964-, et al. (författare)
  • Clinical Impact of Influenza Vaccination after ST- and Non-ST-segment elevation Myocardial Infarction Insights from the IAMI trial
  • 2023
  • Ingår i: American Heart Journal. - : Elsevier. - 0002-8703 .- 1097-6744. ; 255, s. 82-89
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Influenza vaccination early after myocardial infarction (MI) improves prognosis but vaccine effectiveness may differ dependent on type of MI.METHODS: A total of 2571 participants were prospectively enrolled in the IAMI trial and randomly assigned to receive in-hospital inactivated influenza vaccine or saline placebo. The trial was conducted at 30 centers in 8 countries from October 1, 2016 to March 1, 2020. Here we report vaccine effectiveness in the 2467 participants with ST-segment elevation MI (STEMI, n=1348) or non-ST-segment elevation MI (NSTEMI, n=1119). The primary endpoint was the composite of all-cause death, MI, or stent thrombosis at 12 months. Cumulative incidence of the primary and key secondary endpoints by randomized treatment and NSTEMI/STEMI was estimated using the Kaplan-Meier method. Treatment effects were evaluated with formal interaction testing to assess for effect modification.RESULTS: Baseline risk was higher in participants with NSTEMI. In the NSTEMI group the primary endpoint occurred in 6.5% of participants assigned to influenza vaccine and 10.5% assigned to placebo (hazard ratio [HR], 0.60; 95% CI, 0.39-0.91), compared to 4.1% assigned to influenza vaccine and 4.5% assigned to placebo in the STEMI group (HR, 0.90; 95% CI, 0.54-1.50, P=0.237 for interaction). Similar findings were seen for the key secondary endpoints of all-cause death and cardiovascular death. The Kaplan-Meier risk difference in all-cause death at 1 year was more pronounced in participants with NSTEMI (NSTEMI: HR, 0.47; 95% CI 0.28-0.80, STEMI: HR, 0.86; 95% CI, 0.43-1.70, interaction P=0.028).CONCLUSIONS: The beneficial effect of influenza vaccination on adverse cardiovascular events may be enhanced in patients with NSTEMI compared to those with STEMI.
  •  
72.
  • Fröbert, Ole, 1964-, et al. (författare)
  • Influenza Vaccination after Myocardial Infarction : A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
  • 2021
  • Ingår i: Circulation. - : Lippincott Williams & Wilkins. - 0009-7322 .- 1524-4539. ; 144:18, s. 1476-1484
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Observational and small randomized studies suggest that influenza vaccine may reduce future cardiovascular events in patients with cardiovascular disease.Methods: We conducted an investigator-initiated, randomized, double-blind trial to compare inactivated influenza vaccine with saline placebo administered shortly after myocardial infarction (MI) (99.7% of patients) or high-risk stable coronary heart disease (0.3%). The primary endpoint was the composite of all-cause death, MI, or stent thrombosis at 12 months. A hierarchical testing strategy was used for the key secondary endpoints: all-cause death, cardiovascular death, MI, and stent thrombosis.Results: Due to the Covid-19 pandemic, the data safety and monitoring board decided to halt the trial before attaining the prespecified sample size. Between October 1, 2016, and March 1, 2020, 2571 participants were randomized at 30 centers across eight countries; 1290 assigned to influenza vaccine and 1281 to placebo. Over the 12-month follow-up, the primary outcome occurred in 67 participants (5.3%) assigned influenza vaccine and 91 participants (7.2%) assigned placebo (hazard ratio, 0.72; 95% confidence interval, 0.52 to 0.99; P=0.040). Rates of all-cause death were 2.9% and 4.9% (hazard ratio, 0.59; 0.39 to 0.89; P=0.010), of cardiovascular death 2.7% and 4.5%, (hazard ratio, 0.59; 0.39 to 0.90; P=0.014), and of MI 2.0% and 2.4% (hazard ratio, 0.86; 0.50 to 1.46, P=0.57) in the influenza vaccine and placebo groups, respectively. Conclusions: Influenza vaccination early after an MI or in high-risk coronary heart disease resulted in a lower risk of a composite of all-cause death, MI, or stent thrombosis, as well as a lower risk of all-cause death and cardiovascular death at 12 months compared with placebo.Clinical Trial Registration: URL: http://www.clinicaltrials.gov Unique identifier: NCT02831608.
  •  
73.
  • Singh, Gerald G., et al. (författare)
  • Climate impacts on the ocean are making the Sustainable Development Goals a moving target travelling away from us
  • 2019
  • Ingår i: People and Nature. - : John Wiley & Sons. - 2575-8314. ; 1:3, s. 317-330
  • Tidskriftsartikel (refereegranskat)abstract
    • Climate change is impacting marine ecosystems and their goods and services in diverse ways, which can directly hinder our ability to achieve the Sustainable Development Goals (SDGs), set out under the 2030 Agenda for Sustainable Development.Through expert elicitation and a literature review, we find that most climate change effects have a wide variety of negative consequences across marine ecosystem services, though most studies have highlighted impacts from warming and consequences of marine species.Climate change is expected to negatively influence marine ecosystem services through global stressors—such as ocean warming and acidification—but also by amplifying local and regional stressors such as freshwater runoff and pollution load.Experts indicated that all SDGs would be overwhelmingly negatively affected by these climate impacts on marine ecosystem services, with eliminating hunger being among the most directly negatively affected SDG.Despite these challenges, the SDGs aiming to transform our consumption and production practices and develop clean energy systems are found to be least affected by marine climate impacts. These findings represent a strategic point of entry for countries to achieve sustainable development, given that these two goals are relatively robust to climate impacts and that they are important pre-requisite for other SDGs.Our results suggest that climate change impacts on marine ecosystems are set to make the SDGs a moving target travelling away from us. Effective and urgent action towards sustainable development, including mitigating and adapting to climate impacts on marine systems are important to achieve the SDGs, but the longer this action stalls the more distant these goals will become.
  •  
74.
  • Bakx, Tom J. L. C., et al. (författare)
  • ALMA uncovers the [C II] emission and warm dust continuum in a z=8.31 Lyman break galaxy
  • 2020
  • Ingår i: Monthly notices of the Royal Astronomical Society. - : Oxford University Press (OUP). - 0035-8711 .- 1365-2966. ; 493:3, s. 4294-4307
  • Tidskriftsartikel (refereegranskat)abstract
    • We report on the detection of the [C II] 157.7 mu m emission from the Lyman break galaxy (LBG) MACS0416_Y1 at z = 8.3113, by using the Atacama Large Millimeter/submillimeter Array (ALMA). The luminosity ratio of [O III] 88 mu m (from previous campaigns) to [CII] is 9.3 +/- 2.6, indicative of hard interstellar radiation fields and/or a low covering fraction of photodissociation regions. The emission of [C II] is cospatial to the 850 mu m dust emission (90 mu m rest frame, from previous campaigns), however the peak [C II] emission does not agree with the peak [O III] emission, suggesting that the lines originate from different conditions in the interstellar medium. We fail to detect continuum emission at 1.5 mm (160 mu m rest frame) down to 18 mu Jy (3 sigma). This non-detection places a strong limits on the dust spectrum, considering the 137 +/- 26 mu Jy continuum emission at 850 mu m. This suggests an unusually warm dust component (T > 80 K, 90 per cent confidence limit), and/or a steep dust-emissivity index (beta(dust) > 2), compared to galaxy-wide dust emission found at lower redshifts (typically T similar to 30-50 K, beta(dust) similar to 1-2). If such temperatures are common, thiswould reduce the required dust mass and relax the dust production problem at the highest redshifts. We therefore warn against the use of only single-wavelength information to derive physical properties, recommend a more thorough examination of dust temperatures in the early Universe, and stress the need for instrumentation that probes the peak of warm dust in the Epoch of Reionization.
  •  
75.
  •  
76.
  • De Santis, Martina M, et al. (författare)
  • Extracellular-Matrix-Reinforced Bioinks for 3D Bioprinting Human Tissue
  • 2021
  • Ingår i: Advanced Materials. - : Wiley. - 1521-4095 .- 0935-9648. ; 33:3
  • Tidskriftsartikel (refereegranskat)abstract
    • Recent advances in 3D bioprinting allow for generating intricate structures with dimensions relevant for human tissue, but suitable bioinks for producing translationally relevant tissue with complex geometries remain unidentified. Here, a tissue-specific hybrid bioink is described, composed of a natural polymer, alginate, reinforced with extracellular matrix derived from decellularized tissue (rECM). rECM has rheological and gelation properties beneficial for 3D bioprinting while retaining biologically inductive properties supporting tissue maturation ex vivo and in vivo. These bioinks are shear thinning, resist cell sedimentation, improve viability of multiple cell types, and enhance mechanical stability in hydrogels derived from them. 3D printed constructs generated from rECM bioinks suppress the foreign body response, are pro-angiogenic and support recipient-derived de novo blood vessel formation across the entire graft thickness in a murine model of transplant immunosuppression. Their proof-of-principle for generating human tissue is demonstrated by 3D bioprinting human airways composed of regionally specified primary human airway epithelial progenitor and smooth muscle cells. Airway lumens remained patent with viable cells for one month in vitro with evidence of differentiation into mature epithelial cell types found in native human airways. rECM bioinks are a promising new approach for generating functional human tissue using 3D bioprinting.
  •  
77.
  • Golovchenko, A. N., et al. (författare)
  • Fragmentation of 370 MeV/n Ne-20 and 470 MeV/n Mg-24 in light targets
  • 2010
  • Ingår i: Radiation Measurements. - : Elsevier BV. - 1350-4487. ; 45:7, s. 856-860
  • Tidskriftsartikel (refereegranskat)abstract
    • Total charge-changing cross sections and cross sections for the production of projectile-like fragments were determined for fragmentation reactions induced by 370 MeV/n Ne-20 ions in water and lucite, and 490 MeV/n Mg-24 ions in polyethylene, carbon and aluminum targets sandwiched with CR-39 plastic nuclear track detectors. An automated microscope system and a track-to-track matching algorithm were used to count and recognize the primary and secondary particles. The measured cross sections were then compared with published cross sections and predictions of different models. Two models and the three-dimensional Monte Carlo Particle Heavy Ion Transport Code System (PHITS) were used to calculate total charge-changing cross sections. Both models agreed within a few percent for the system Mg-24 + CH2, however a deviation up to 20% was observed for the systems Ne-20 + H2O and C5H8O2, when using one of the models. For all the studied systems, PHITS systematically underestimated the total charge-changing cross section. It was also found that the partial fragmentation cross sections for Mg-24 + CH2 measured in present and earlier works deviated up to 20% for Z = 6-11. Measured cross sections for the production of fragments (Z = 4-9) for Ne-20 + H2O and C5H8O2 were compared with predictions of three different semi-empirical models and JQMD which is used in the PHITS code. The calculated cross sections differed from the measured data by 10-90% depending on which fragment and charge was studied, and which model was used. (C) 2010 Elsevier Ltd. All rights reserved.
  •  
78.
  • Ju, Ying, et al. (författare)
  • Joint Secure Offloading and Resource Allocation for Vehicular Edge Computing Network : A Multi-Agent Deep Reinforcement Learning Approach
  • 2023
  • Ingår i: IEEE transactions on intelligent transportation systems (Print). - : Institute of Electrical and Electronics Engineers (IEEE). - 1524-9050 .- 1558-0016. ; 24:5, s. 5555-5569
  • Tidskriftsartikel (refereegranskat)abstract
    • The mobile edge computing (MEC) technology can simultaneously provide high-speed computing services for multiple vehicular users (VUs) in vehicular edge computing (VEC) networks. Nevertheless, due to the open feature of the wireless offloading channels and the high mobility of the vehicles, the security and stability of the offloading process would be seriously degraded. In this paper, by utilizing the physical layer security (PLS) technique and spectrum sharing architecture, we propose a deep reinforcement learning based joint secure offloading and resource allocation (SORA) scheme to improve the secrecy performance and resource efficiency of the multi-user VEC networks, where the VU offloading links share the frequency spectrum preoccupied with the vehicle-to-vehicle (V2V) communication links. We use Wyner's wiretap coding scheme to obtain the achievable secrecy rate and guarantee that confidential information cannot be decoded by multiple mobile eavesdroppers. We aim at minimizing the system processing delay while securing the wireless offloading process, by jointly optimizing the transmit power, the frequency spectrum selection and the computation resource allocation. We formulate the optimization problem as a multi-agent collaborative optimal decision problem and solve it with a double deep Q-learning algorithm. Besides, we set a punishment mechanism for the rate degradation to guarantee the communication quality of each V2V link. Simulation results demonstrate that multiple VU agents adopting the SORA scheme can rapidly adapt to the highly dynamic VEC networks and cooperate to improve the system delay performance while increasing the secrecy probability.
  •  
79.
  •  
80.
  • Marlevi, David, doktorand, et al. (författare)
  • Combined spatiotemporal and frequency-dependent shear wave elastography enables detection of vulnerable carotid plaques as validated by MRI
  • 2020
  • Ingår i: Scientific Reports. - : Springer Nature. - 2045-2322. ; 10:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Fatal cerebrovascular events are often caused by rupture of atherosclerotic plaques. However, rupture-prone plaques are often distinguished by their internal composition rather than degree of luminal narrowing, and conventional imaging techniques might thus fail to detect such culprit lesions. In this feasibility study, we investigate the potential of ultrasound shear wave elastography (SWE) to detect vulnerable carotid plaques, evaluating group velocity and frequency-dependent phase velocities as novel biomarkers for plaque vulnerability. In total, 27 carotid plaques from 20 patients were scanned by ultrasound SWE and magnetic resonance imaging (MRI). SWE output was quantified as group velocity and frequency-dependent phase velocities, respectively, with results correlated to intraplaque constituents identified by MRI. Overall, vulnerable lesions graded as American Heart Association (AHA) type VI showed significantly higher group and phase velocity compared to any other AHA type. A selection of correlations with intraplaque components could also be identified with group and phase velocity (lipid-rich necrotic core content, fibrous cap structure, intraplaque hemorrhage), complementing the clinical lesion classification. In conclusion, we demonstrate the ability to detect vulnerable carotid plaques using combined SWE, with group velocity and frequency-dependent phase velocity providing potentially complementary information on plaque characteristics. With such, the method represents a promising non-invasive approach for refined atherosclerotic risk prediction.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 71-80 av 88
Typ av publikation
tidskriftsartikel (82)
forskningsöversikt (3)
konferensbidrag (1)
Typ av innehåll
refereegranskat (82)
övrigt vetenskapligt/konstnärligt (4)
Författare/redaktör
Fischer, F (18)
Hamidi, S (17)
Koyanagi, A (17)
Vos, T (17)
Majeed, A (16)
Monasta, L (16)
visa fler...
Moradi-Lakeh, M (16)
Morawska, L (16)
Yonemoto, N (16)
Ahmad Kiadaliri, Ali ... (16)
Kim, D. (15)
Larsson, Anders (15)
Dandona, R (15)
Farzadfar, F (15)
Malekzadeh, R (15)
Mendoza, W (15)
Roshandel, G (15)
Topor-Madry, R (15)
Gupta, R. (14)
Abd-Allah, F (14)
Alvis-Guzman, N (14)
Catala-Lopez, F (14)
Dandona, L (14)
Das Neves, J (14)
Deribe, K (14)
Faro, A (14)
Jahanmehr, N (14)
Karch, A (14)
Leigh, J (14)
Lunevicius, R (14)
Meretoja, A (14)
Nangia, V (14)
Radfar, A (14)
Ronfani, L (14)
Sartorius, B (14)
Venketasubramanian, ... (14)
Zodpey, S (14)
Alam, K (13)
Badawi, A (13)
Bedi, N (13)
Kabir, Z (13)
Mohammed, S (13)
Naghavi, M (13)
Oren, E (13)
Polinder, S (13)
Pourmalek, F (13)
Shiri, R (13)
Tabares-Seisdedos, R (13)
Petzold, Max, 1973 (13)
Rahman, M (13)
visa färre...
Lärosäte
Karolinska Institutet (49)
Lunds universitet (28)
Uppsala universitet (24)
Göteborgs universitet (20)
Högskolan Dalarna (20)
Stockholms universitet (16)
visa fler...
Chalmers tekniska högskola (11)
Umeå universitet (9)
Kungliga Tekniska Högskolan (9)
Örebro universitet (4)
Linköpings universitet (4)
Luleå tekniska universitet (3)
Södertörns högskola (3)
Jönköping University (1)
Mittuniversitetet (1)
visa färre...
Språk
Engelska (87)
Japanska (1)
Forskningsämne (UKÄ/SCB)
Naturvetenskap (34)
Medicin och hälsovetenskap (32)
Teknik (3)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy